Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: The 33-year-old could not find help for her toothache even after she fled Islamic State rule and took refuge in northwest Syria. But a dentist in a mobile clinic has now arrived at the Rayyan camp where she lives with her husband and four children in a tent among the trees. “We kept getting uprooted, so we were cut off from doctors,” said Abdelaziz, whose family was smuggled out of Raqqa city some three years ago. They wound up in Syria’s northwest corner, the country’s last major rebel stronghold. The camps are overflowing, the doctors are too few, and many hospitals have collapsed under government bombing. In the camps along the Turkish border, often the only healthcare for people like Abdelaziz comes from mobile doctors and makeshift clinics in tents. “Many just take pills and stay silent about the pain,” said Bassel Maarawi, 57, the dentist who goes around seven camps in the border strip held by Turkey-backed rebels. The dental mobile clinic stays at each camp a few months at a time, treating dozens of patients every day who can not go into town to see a doctor. It belongs to the Independent Doctors Association, a Turkey-based Syrian group also running a free camp facility including a clinic for women, children, and internal medicine as well as a pharmacy. Maarawi himself was uprooted in late 2016 from his city of Aleppo, where the army crushed rebels with Russia and Iran’s help after a bitter siege. The children he treats now, living in the dirt and drinking filthy water, often suffer from malnutrition. “Many people were displaced recently which really affected them mentally, you can see it when they come in,” he said. A new wave of fighting has sparked yet another exodus, with hundreds of thousands of people fleeing an army offensive in northwest Syria since April. At a camp for some 14,000 people in the border village of Shamarin, Ammar al-Omar runs a physiotherapy clinic inside a large tent. The staff - a medical professional and three volunteers he trained - made most of the equipment themselves and get by on just a few donations. They treat everything from back pain to battle wounds for patients including rebel fighters and paralyzed children. “There are many injuries because of the fierce bombing,” Omar said. “The patients can’t afford food let alone transportation.”   Um Mhamad, 29, has carried her son from another camp nearby and walked to the tent clinic for more than two years. An injury at birth had crippled the six-year-old boy, whose family was shuttled out of Aleppo in 2016. “He used to not move at all,” she said. “Today, he can crawl and turn on both sides and stand up.” Claim: In border camps, Syrians rely on doctors in trucks and tents.

A: The Syrian war has inflicted all kinds of hardships on Najwa Abdelaziz but she still manages to make light of one of them. “The uprising ruined my teeth,” she jokes while getting dental care for the first time in years in the back of a truck.
****
Q: Paragraph: A Berne court found the man guilty of causing bodily harm and spreading the virus which can cause Aids, court secretary Rene Graf told Reuters. He did not give any further details. Prosecutors had sought a sentence of 15 years in jail, according to media reports. “The accused and nobody else is responsible for infecting the 16 people,” Swiss news agency SDA quoted court president Urs Herren as saying, adding the man’s motive could have been to seek attention, exact revenge, or prove his omnipotence. The 54-year-old from the Swiss capital Berne had consistently denied the charges, blaming the victims for contracting HIV through unprotected sex and intravenous drug use, Swiss media reported. They did not reveal the man’s identity or nationality, in accordance with rules on Swiss criminal proceedings. The case came to the attention of the authorities after an HIV-positive patient told a hospital he suspected his infection was linked to acupuncture treatments he received from the man. The majority of the infected individuals were students of a music school run by the man, who also had an acupuncture practice. Some of the victims told the court he stabbed them with a needle from behind during treatment, SDA reported. Police stormed the man’s home a week ago after he stopped coming to the trial. The man, who was free on bail, had barricaded himself inside and was armed with a knife, issuing threats to police, according to media reports. Claim: "Swiss court jails ""healer"" for infecting 16 with HIV."

A: A self-styled healer was sentenced to 12 years and nine months in jail on Friday after a Swiss court found the acupuncturist guilty of infecting 16 people with HIV.
****
Q: Paragraph: "The article is sufficiently clear that the drug is generic and inexpensive. Because this use would be novel, and not used as an alternative to existing treatments, more information about its cost is not required. While the report uses study data to describe the findings, it does not clarify what those findings mean to people who have had strokes. The findings indicate the drug group (NIHSS scale rating 1.6) had ""little nor no disability,"" and the placebo group (rating 6.5) ""the high end of mild disability."" Translating these into specific symptoms (slurred speech, difficulty walking, cognitive impairment, etc.) would be useful. It’s also not clear how high the stroke scale goes–to 10? 15? 20? Knowing that would help readers understand the magnitude of the difference. Finally, the study found that there was no difference in heart attacks, additional strokes or deaths between the two groups. Data on these critical outcomes should have been reported. One credible source states that the antibiotic has a well established safety record. Other sources confirm this indirectly. Because the potential benefit is so large–preventing permanent brain damage resulting from a stroke–minor side effects are not essential to mention. It would have been useful to know, however, whether this drug could interact with clot-busting medications if they are given within the three-hour window. The article indicates that the study is small and the first to produce these findings. It also explains that it was an ""open label"" study, meaning the patients knew whether they were getting the antibiotic or a placebo. Several sources reiterate that the findings are preliminary and require replication. The reporter also mentions that a similar study of a neuroprotective agent had promising results but was later shown ineffective in a larger study. This context is very useful; it discourages readers from jumping to conclusions about this study’s value. The article does nothing to exaggerate the effects of stroke or the drug’s capacity to minimize them. The writer interviews four independent sources in addition to the study author, an unusual amount of reporting on a single study that adds to the story’s value. The article makes clear that the study was not funded by an interested party, which also adds credibility to the findings. The article makes clear that there are no treatment options outside the 3-hour treatment window when administration of the IV clot-buster tPA is effective at protecting against brain damage. The article makes clear that the drug is cheap and widely available, but properly adds that any use as a treatment for stroke would be off-label at a doctor’s discretion. The report makes clear that the use of the antibiotic as a neuroprotective agent is novel, though the product is widely used for other purposes. There is no evidence the article was based on the press release." Claim: Antibiotic might help after stroke, study says

A:
"This article on a study about potential benefits of the antibiotic minocycline in reducing brain damage when given up to 24 hours after a stroke is very well balanced and reported. It makes clear that the findings are promising but preliminary, and that any clinical application at this point would be off-label and at a physician’s discretion. The reporter explores the question of clinical application with four independent sources, which permits a reader to understand more fully how and under what circumstances the drug might be used. The report would have been stronger if the differences in symptoms between the drug group and the placebo group had been detailed. Stroke symptoms can be mild or debilitating, and it’s not clear exactly how much practical benefit the treatment provides. The report is particularly strong at the top: the author properly uses the word ""intriguing"" when the study is first mentioned, which keeps expectations in check. The following paragraph says ""more research is needed to confirm"" the findings. Too often these qualifiers are buried deeper in a story. We’re pleased to give this story one of our highest five-star scores."
****